Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neuroblastoma 3Lymphoma 3Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Unspecified Childhood Solid Tumor, Protocol Specific 1Subcutaneous panniculitis-like T-cell lymphoma 1Sertoli-Leydig Cell Tumor 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian gynandroblastoma 1Ovarian Neoplasms 1Neoplasms 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lung Neoplasms 1Leukemia 1Immunoblastic Lymphadenopathy 1Granulosa cell tumor of the ovary 1Glioma 1Fallopian Tube Neoplasms 1Enteropathy-Associated T-Cell Lymphoma 1Carcinoma, Ovarian Epithelial 1

Interventions

Carboplatin 15Paclitaxel 13Hyperthermic Intraperitoneal Chemotherapy 6Cisplatin 5olaparib 4niraparib 4Bevacizumab 4oregovomab 3Topotecan 3Immunohistochemistry 3Gemcitabine 3Drug Therapy 3Docetaxel 3Cyclophosphamide 3Chemotherapy, Adjuvant 3Amplified Fragment Length Polymorphism Analysis 3pembrolizumab 2liposomal doxorubicin 2anlotinib 2ST 1481 2Radiotherapy 2Polymerase Chain Reaction 2Oxaliplatin 2Neoadjuvant Therapy 2Gene Expression Profiling 2Fluorouracil 2Flow Cytometry 2Diathermy 2Cytoreduction Surgical Procedures 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Ovarian Epithelial × etoposide phosphate × Clear all
NCT00003064 2014-01-06

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
30 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡